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Abstract
Background: The development of spasticity with age in children with cerebral palsy (CP) has, to
our knowledge, not been studied before. In 1994, a register and a health care program for children
with CP in southern Sweden were initiated. In the programme the child's muscle tone according to
the modified Ashworth scale is measured twice a year until six years of age, then once a year. We
have used this data to analyse the development of spasticity with age in a total population of
children with cerebral palsy.
Methods: All measurements of muscle tone in the gastrocnemius-soleus muscle in all children
with CP from 0 to 15 years during the period 1995–2006 were analysed. The CP subtypes were
classified according to the Surveillance of Cerebral Palsy in Europe network system. Using these
criteria, the study was based on 6218 examinations in 547 children. For the statistical analysis the
Ashworth scale was dichotomized. The levels 0–1 were gathered in one category and levels 2–4 in
the other. The pattern of development with age was evaluated using piecewise logistic regression in
combination with Akaike's An Information Criterion.
Results: In the total sample the degree of muscle tone increased up to 4 years of age. After
4 years of age the muscle tone decreased each year up to 12 years of age. A similar development
was seen when excluding the children operated with selective dorsal rhizotomy, intrathecal
baclofen pump or tendo Achilles lengthening. At 4 years of age about 47% of the children had
spasticity in their gastro-soleus muscle graded as Ashworth 2–4. After 12 years of age 23% of the
children had that level of spasticity. The CP subtypes spastic bilateral and spastic unilateral CP
showed the same pattern as the total sample. Children with dyskinetic type of CP showed an
increasing muscle tone up to age 6, followed by a decreasing pattern up to age 15.
Conclusion: In children with CP, the muscle tone as measured with the Ashworth scale increases
up to 4 years of age and then decreases up to 12 years of age. The same tendency is seen in all
spastic subtypes. The findings may have implications both for clinical judgement and for research
studies on spasticity treatment.
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The spastic subtypes are the most common manifesta-
tions of cerebral palsy (CP) [1]. Spasticity is defined as "a
velocity-dependent increase in tonic stretch reflexes
(muscle tone) with exaggerated tendon jerks, resulting
from hyperexcitability of the stretch reflex, as one
component of the upper motor neurone syndrome" [2].
It is well known that children with spastic types of CP
often have a normal or low muscle tone in the newborn
period [3]. During the first years of life the muscle tone
increases, and by age 4 it should be possible to diagnose
the spasticity in all children with spastic CP [4].
However, the further development of spasticity with
age has, to our knowledge, not been studied before.
In 1994, a cerebral palsy register and a health care
programme were initiated for children with CP in
southern Sweden [5, 6]. The child's local physiotherapist
fills in a recording form twice a year until six years of age,
then once a year. The recording form includes measure-
ment of muscle tone according to the modified Ash-
worth scale [7] (Table 1).
We have used this data to analyse the development of
spasticity with age in a total population of children with
cerebral palsy.
Methods
The CPUP register includes all children with CP born
after 1 January 1990 living in the counties of Skåne and
Blekinge in southern Sweden, which have a total
population of about 1.3 million. The number of children
with CP in the area corresponds to a prevalence of 2.4
per 1000 living births [8, 9]. Since 2005, CPUP has been
a National Health Care Quality Register approved by the
National Board of Health and Welfare in Sweden.
The programme includes a continuing standardized
follow-up of gross and fine motor function, clinical
findings and treatment. The child's local physiothera-
pists examine the child and fill in the recording form
twice a year until six years of age, then once a year. There
are 13 child habilitation units in the area, with about
80 physiotherapists involved in the CPUP-programme.
The recording form includes the CP subtype, as well as
measurement of muscle tone according to the modified
Ashworth scale [7] (Table 1). The measurements are
performed in stated and standardized positions
described in a manual connected to the recording form.
In the present study all measurements of muscle tone in
the gastrocnemius-soleus muscle in all children with CP
from 0 to 15 years of age during the period 1995 – 2006
were analysed. The measurements were done with the
child lying prone with the hip and knee extended. Only
children with definite diagnosis of CP were included.
The CP subtypes were classified according to the
Surveillance of Cerebral Palsy in Europe network
(SCPE) [10]. In children with unilateral spastic CP,
only the spastic side was used in the analysis. In all other
cases both sides were used.
Using these criteria, the study was based on 6218
examinations in 547 children. The distribution of CP
subtypes and measurements are presented in Tables 2 and
3. The children treated with selective dorsal rhizotomy
(SDR), intrathecal baclofen pump (ITB), tendo Achilles or
gastrocnemius lengthening (TAL) are known (Table 4). The
results are presented with these children both included and
excluded. During the period 104 children were treated with
botulinumtoxin A (BxA) of the gastrocnemius-soleus
muscle on 262 occasions. The distribution of age at time
of treatment is presented in Figure 1. In most cases the
measurement of muscle tone was done more than three
months after BxA treatment. The children treated with BxA
are included in the study.
In the statistical analysis the Ashworth scale was dichot-
omized. Levels 0, 1 and 1+ were gathered in one category
and levels 2, 3 and 4 in the other. The analysis then focused
on estimating the age effects on the risk of sustaining an
Ashworth level of 2 or above. It was implemented using
the logistic regression algorithms in STATA 9.0 [11].
Consideration of the correlation structure imposed by the
Table 1: The modified Ashworth scale
Score Description of the muscle tone
0 Normal tone, no increase in tone
1 Slight increase in tone – a catch and release at the end of
the range of motion
1+ Slight increase in tone – catch, followed by minimal
resistance in remainder of range
2 More marked increase in tone through most of range
3 Considerable increase in tone, passive movement difficult
4 Affected parts rigid in flexion or extension
Table 2: Distribution of children and examinations in relation to
CP subtypes based on the Surveillance of Cerebral Palsy in
Europe (SCPE).
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inclusion of data on both legs for most children was given
through the use of robust estimates.
In order to allow for a potential change in the direction
of the development of spasticity with age, linear splines
were used in the logistic regression analysis. The linear
splines construction allows for a change in the estimated
increase or decrease of risk with age, at a pre-specified
age. Different placement and combinations of turning
points in the development with age were evaluated using
Akaike's An Information Criterion (AIC) [12].
Intuitively one can think of this process as determining
the age development pattern most likely to have
generated the data, while correcting for the number of
parameters used to describe it. The correction is needed
since an increase in parameters tends to enhance the
pattern fit to data without reflecting any valuable
information. Therefore the number generated by the
AIC can be thought of as corresponding to the
probability that the given development pattern gener-
ated the data, penalized with respect to its number of
parameters.
Furthermore, since a perceived change in the risk of
sustaining an Ashworth level of 2 or above, could be a
consequence of late inclusion and early dropout of
different birth cohorts, having been exposed to different
methods of treatment, consideration was also given the
difference between the actual longitudinal age effects of
interest, and cross-sectional birth cohort effects. This
possibility was evaluated by jointly estimating age and
birth cohort effects in the logistic regression analysis.
Results from the analysis can be considered to reflect the
average development of spasticity with age taken over
each of the birth cohorts.
The estimates produced in the analysis can be interpreted
as relative risks. For instance, when a result states that the
odds ratio is 1.5 from 0 to 3 years of age and 0.80 from 3
to 9 years of age, the relative risk interpretation of the
estimates finds that the risk increases by 50% each year
up to the age of 3. It then diminishes by 20% each year
from then on up until the age of 9.
Results
The analysis of the development of spasticity using
Akaike's AIC is presented in Table 5, and the relative risk
estimates are presented in Tables 6 and 7.
In the total population the degree of muscle tone
increased up to 4 years of age (p < 0.05). After 4 years
of age the muscle tone decreased each year up to 12 years
of age (p < 0.05). After 12 years of age no significant
change in development is seen (Figure 2). The analysis of
the possible effect of different birth cohorts did not show









1 37 58 30 6 131
2 84 242 75 20 421
3 130 369 102 40 641
4 152 469 105 48 774
5 187 482 92 71 832
6 139 359 92 54 644
7 88 284 60 44 476
8 97 250 50 45 442
9 88 243 50 38 419
10 71 198 54 34 357
11 60 172 42 32 306
12 49 147 44 36 276
13 46 122 38 30 236
14 27 72 26 28 153
15 14 54 22 20 110
Total 1269 3521 882 546 6218
Table 4: Number of children (examinations) treated with
selective dorsal rhizotomy (SDR), intrathecal baclofen pump
(ITP) or tendo Achilles lengthening (TAL).
CP sub-
type
SDR ITB TAL Total
Spastic
unilateral 24 (211) 24(211)
bilateral 32 (594) 10 (194) 27 (441) 66 (1165)
Dyskinetic 6 (84) 4 (64) 9 (132)
Ataxic 1 (20) 1 (20)
Total 32 (594) 16 (278) 56 (736) 100 (1528)
Three children have been treated with both TAL and SDR and one child
with both TAL and ITB.
Figure 1
Number of treatments with BxA related to age at
time of treatment in the total sample of children
with CP.
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any differences explaining the pattern of development
(Table 7). When the children operated with SDR, ITB or
TAL were excluded, the turning points were 6 and 12
years, i.e. the degree of muscle tone increased up to 6
years of age (p < 0.05), then decreased between 6 and 12
yrs of age (Figure 3).
At 4 years of age 47% of the total population of children
with CP had spasticity in their gastro-soleus muscle
graded as Ashworth 2–4. After 12 years of age 23% of the
children had that level of spasticity.
The children with spastic unilateral CP showed an
increasing muscle tone up to 4 years of age, followed
by a decreasing tone up to 11 years of age (p < 0.05,
Figure 4). After 11 years of age an increasing muscle tone
was registered when children operated with TAL were
included (p < 0.05). When those operated with TAL were
excluded, no statistically significant change in muscle
tone was seen after 7 years of age (Figure 5).
The CP subtype spastic bilateral showed almost the same
pattern as the total sample, with turning points at 3 and
12 years (Figure 6). Of the 266 children with bilateral
CP, 66 had been operated with SDR, ITB or TAL (Table 4).
Excluding these children, the turning points shifted to 7
and 12 years (Figure 7).
The children with the dyskinetic type of CP showed an
increasing muscle tone up to age 6 (P < 0.05), followed
by a decreasing pattern up to age 15 (p < 0.05) (Figure 8).
Excluding the 9 children operated with ITB or TAL did not
change the results.
The children with ataxic type of CP had, as expected, on
average a lower degree of spasticity (Figure 9). In the
SCPE classification, children with ataxic diplegia are
classified as ataxic CP. The number of measurements did
not allow for analysis using Akaike's AIS.
Discussion
The development of spasticity with age in children with
CP has, to our knowledge, not been analysed before. The
study showed an increasing muscle tone up to 4 years of
age in children with spastic CP and up to 6 years in
children with dyskinetic CP, followed by a decreasing
tone up to 12 years of age.
In the 1990s two new methods to reduce spasticity in
children with CP were introduced, ITB and BxA
treatment. In the same period treatment with SDR was
popularized [13]. These techniques made it important to
quantify spasticity, both for analysing indication and for
evaluation of treatment.
The modified Ashworth scale is the most widely used
instrument for assessing spasticity, and it has been used
in most outcome studies after treatment with SDR, ITB
and BxA [1]. No other instrument is so simple that it can
be used for screening purpose or clinical follow-up of
larger samples. The modification from the original scale
is the addition of one level of measurement (1+) at the
lower end of the scale. There is no evidence supporting




No turning point 1.2952
Turning point at 4 years 1.2921
Turning point at 4 and 12 years 1.2902
Total population – children operated* excluded
No turning point 1.2893
Turning point at 6 years 1.2838
Turning point at 6 and 12 years 1.2822
Spastic unilateral CP
No turning point 1.1901
Turning point at 4 years 1.1795
Turning point at 4 and 11 years 1.1698
Spastic unilateral CP-children operated* excluded
No turning point 1.2099
Turning point at 4 years 1.1948
Turning point at 7 and 7 years 1.1918
Spastic bilateral CP
No turning point 1.3338
Turning point at 3 years 1.1317
Turning point at 3 and 12 years 1.3305
Spastic bilateral CP – children operated* excluded
No turning point 1.3508
Turning point at 7 years 1.3469
Turning point at 7 and 12 years 1.3449
Dyskinetic CP
No turning point 1.3605
Turning point at 6 years 1.3448
Dyskinetic CP – children operated* excluded
No turning point 1.3301
Turning point at 6 years 1.2928
In each subgroup the AIC value for an age development pattern without
turning point, an age development pattern with turning points and age at
turning points that yielded the lowest AIC value are presented.
* Children operated with SDR, ITB and/or TAL excluded
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an ordinal relationship between level 1 and level 1+, and
there is a lack of evidence for the relation between the
introduced terms "catch" and "release" to the definition of
spasticity as resistance to passive movement [14]. Some
studies have shown problems with interobserver reliability
with the Ashworth scale [15, 16]. The reliability is better
with the original scale, as is measuring plantar flexion of
the ankle compared with measurement of more proximal
muscles [15, 17]. Some of these problems regarding scaling
and reliability are reduced as the scale in the present study
was dichotomized and grouping level 1 and 1+ together.
The main reason for dichotomizing the Ashworth scale
was to make possible the modelling process in which we
determine the number of age intervals and their
corresponding endpoints. We wanted to estimate the
development of spasticity with age with a method that
would supply equivalent estimates and confidence
intervals for all CP-subtypes. Additionally, the method
should allow for the possibility of a change of
magnitude and direction of this development. This was
not likely to be possible with any other method.
It is sometimes difficult to distinguish limb stiffness
resulting from muscle shortening from stiffness caused
by spasticity [17]. As muscle stiffness increases with age
[19, 20] the problem with differentiating shortening
from spasticity would result in an underestimation of the
decreasing spasticity with age found in this study. It
could also be an explanation for the increased muscle
tone registered after 11 years of age in children with
unilateral CP. The problem is reduced by grouping levels
2–4 together in the analysis. In the present analysis a low
reliability would, in absence of systematic errors, only
increase the observed variation in the population
spasticity measurements, with increased confidence
interval width. A low reliability should only affect our
ability to correctly detect an actual change.
Table 6: Relative risk estimates i.e. the risk of sustaining a level of spasticity greater than or equal to 2 as compared to the year before,
in different subgroups and age periods.
Population Age period and relative risk estimates
Total population < 4 yrs 4–12 yrs > 12 yrs
1.15(1.06–1.26)* 0.87(0.85–0.89)* 1.08(0.97–1.19)
Total population – op
excluded1
< 6 yrs 6–12 yrs > 12 yrs
1.08(1.02–1.13)* 0.84(0.80–0.87)* 1.06(0.94–1.20)
Spastic unilateral CP < 4 yrs 4–11 yrs > 11 yrs
1.44(1.18–1.76)* 0.78(0.73–0.84)* 1.24(1.03–1.50)*
Spastic unilateral CP – op
excluded1
< 4 yrs 4–7 yrs > 7 yrs
1.63(1.27–2.08)* 0.73(0.62–0.85)* 0.94(0.86–1.04)
Spastic bilateral CP < 3 yrs 3–12 yrs > 12 yrs
1.33(1.07–1.64)* 0.88(0.86–0.91)* 1.06(0.93–1.21)
Spastic bilateral CP – op
excluded1
< 7 yrs 7–12 yrs > 12 yrs
1.08(1.00–1.12) 0.83(0.77–0.89)* 1.09(0.92–1.27)
Dyskinetic CP < 6 yrs > 6 yrs
1.15(1.03–1.27)* 0.84(0.74–0.97)*
Dyskinetic CP – op excluded1 < 6 yrs > 6 yrs
1.23(1.09–1.39)* 0.76(0.70–0.83)*
In brackets 95% confidence interval.
* p < 0.05 for the two-sided test of the relative risk being equal to 1.
1 excluded operations; SDR, ITB, TAL
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The validity of the Ashworth scale has been analysed in
several studies [1]. Pandyan et al. [21] compared
measurement of resistance to passive movement of the
elbow with estimation of spasticity according to the
modified Ashworth scale in adult stroke patients. They
concluded that the modified Ashworth scale did not
have sufficient validity to discriminate between the lover
levels, but may be useful as a scale with fewer grades.
Leonard et al. [22] compared the modified Ashworth
scale with myometer measurement of the biceps brachii
and found moderate to high correlation between the
methods. Sköld et al. [23] compared EMG-measurement
of the quadriceps with estimation of spasticity according
to the modified Ashworth scale in adults with spinal
cord injury. They found a positive correlation and
concluded that the modified Ashworth scale accurately
reflect movement-provoked spasticity. Each increasing
grade on the Ashworth scale corresponded to increasing
myoelectric activity levels.
Most of the children treated with BxA were 3–5 years of
age at time of treatment (Figure 1). They were most often
Table 7: Relative risk estimates i.e. the odds of sustaining a level of spasticity greater than or equal to 2 as compared to the year before,
in different subgroups and age periods.
Population Age period and relative risk estimates
Total population < 4 yrs 4–12 yrs > 12 yrs
1.10(1.00–1.20)* 0.85(0.82–0.87)* 1.07(0.97–1.20)
Total population – op excluded1 < 6 yrs 6–12 yrs > 12 yrs
1.04(0.98–1.10) 0.84(0.80–0.88)* 1.10(0.96–1.25)
Spastic unilateral CP < 4 yrs 4–11 yrs > 11 yrs
1.29(1.05–1.58)* 0.76(0.71–0.82)* 1.29(1.05–1.57)*
Spastic unilateral CP – op excluded1 < 4 yrs 4–7 yrs > 7 yrs
1.46(1.14–1.88)* 0.65(0.54–0.77)* 0.96(0.87–1.06)
Spastic bilateral CP < 3 yrs 3–12 yrs > 12 yrs
1.24(1.00–1.55)* 0.86(0.83–0.86)* 1.08(0.94–1.024)
Spastic bilateral CP – op excluded1 < 7 yrs 7–12 yrs > 12 yrs
1.04(0.98–1.11) 0.83(0.77–0.90)* 1.13(0.95–1.33)
Dyskinetic CP < 6 yrs > 6 yrs
1.28(1.13–1.45)* 0.82(0.76–0.88)*
Dyskinetic CP – op excluded1 < 6 yrs > 6 yrs
1.39(1.21–1.60)* 0.80(0.73–0.88)*
Estimates corrected for potential differences in risk of separate birth cohorts. In brackets 95% confidence interval.
* p < 0.05 for the two-sided test of the relative risk being equal to 1.
1 excluded operations; SDR, ITB, TAL
Figure 2
Degree of spasticity in the gastrocnemius-soleus
muscle according to the modified Ashworth scale
related to age in the total sample of children with CP
(547 children, 6218 measurements). Number of mea-
surements presented as a percentage of the total number of
measurements in each age group.
Figure 3
Degree of spasticity in the total sample according to
Figure 2. Children treated with SDR, ITB or TAL excluded.
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examined more than three months after treatment. As
the majority of treatments were done at the same age
period as the highest degree of muscle tone was found,
compensation for a possible treatment effect would
strengthen the pattern of increasing spasticity followed
by decreasing spasticity with age.
Spasticity and decreased active muscle strength are the
two predominant symptoms in children with CP [24].
The decreased active muscle strength is to some extent
compensated by the passive strength that is created by
spasticity. Thus, increased muscle tone is sometimes
valuable, and treatment of spasticity should aim at
modulating the muscle tone for their maximum benefit.
The findings in the present study may have several
clinical implications. The decreasing spasticity with age
is in accordance with the clinical findings that some
children with toe walking gait, if they do not develop
muscle shortening, after some years start walking with
heel contact [25]. This could be a consequence of the
increasing body weight and/or a result of decreasing
muscle tone with age.
The decreasing spasticity with age must also be kept in
mind when considering treatment with methods perma-
nently reducing spasticity, such as SDR, or when
considering TAL. Some children treated with SDR after
some years, with increasing body weight and height,
Figure 4
Degree of spasticity in the gastrocnemius-soleus
muscle according to the modified Ashworth scale
related to age in the total sample of children with
unilateral CP (186 children, 1269 measurements).
Number of measurements presented as a percentage of the
total number of measurements in each age group.
Figure 5
Degree of spasticity children with unilateral CP
according to Figure 4. Children treated with TAL
excluded.
Figure 6
Degree of spasticity in the gastrocnemius-soleus
muscle according to the modified Ashworth scale
related to age in the total sample of children with
bilateral CP (266 children, 3521 measurements).
Number of measurements presented as a percentage of the
total number of measurements in each age group.
Figure 7
Degree of spasticity in the children with bilateral CP
according to Figure 5. Children treated with SDR, ITB or
TAL excluded.
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have increasing problems with muscle weakness [26].
Perhaps at that age they would have benefited from more
passive muscle strength by a higher muscle tone. The
finding that spasticity is not a constant phenomenon
favours treatment with reversible methods, such as BxA
and ITB. The decreasing muscle tone and the increasing
weakness related to body weight and height must also be
kept in mind when considering TAL. A crouch gait after
TAL could be caused by over-lengthening, but also a
consequence of a decreasing muscle tone of the gastro-
cnemius-soleus muscle.
The findings are also important for follow-up studies
after spasticity reducing treatment. The decreasing
muscle tone with age raises the need for control groups
and long-term follow-up when evaluating treatments
that permanently affect the muscle tone, muscle length
and muscle strength, such as SDR and orthopaedic
surgery.
Conclusion
The present study showed that in children with CP, the
muscle tone measured with the Ashworth scale increases
up to 4 years of age and then decreases up to 12 years of
age. The same tendency is seen in all spastic subtypes.
This is, to our knowledge, the first report showing this
development, and thus needs confirmation in further
longitudinal studies. The findings may have implications
both for clinical judgement and for research studies on
spasticity treatment.
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